Sky Oncology LLP
About Sky Oncology LLP
Data last updated:
Sky Oncology LLP is a limited liability partnership (LLP) based in Thane, Maharashtra, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 03 August 2023.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN ACC-3452.
The LLP has a total obligation of contribution of ₹15 Lakh. It is led by designated partners including Viraj Vilas Nevrekar and Salil Vijay Patkar.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Office No 47 And 48 Third Floor Plot No 77 Sector 17 Vashi Thane, Maharashtra, India – 400703.
As per the financials filed for FY 2025, the LLP reported a revenue of ₹18.06 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹87.4 Lakh (net margin 4.8%).
The LLP is associated with 1 brand: ICTC Indian Cancer Treatment Centre.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No 47 And 48 Third Floor Plot No 77 Sector 17 Vashi Thane, Maharashtra, India – 400703
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Sky Oncology LLP
Sky Oncology operates one associated brand: ICTC Indian Cancer Treatment Centre. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides oncology services including chemotherapy, immunotherapy, and bone marrow transplants in multiple centers. | ictconco.org |
Competitors & Alternatives of Sky Oncology LLP
Brands and companies operating in the same space as Sky Oncology LLP include Optimus Oncology, Comprehensive Blood & Cancer Center, Sunrise Oncology Centre and 3 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Optimus Oncology | Radiation oncology services are delivered for comprehensive cancer care. | Nashik, India | 2016 |
 Comprehensive Blood & Cancer Center | Oncology services are delivered via a chain of specialized centers. | Gandhinagar, India | 1984 |
 Sunrise Oncology Centre | Operates a chain of oncology clinics offering specialized cancer care services. | Mumbai, India | 2015 |
 PurpleRibbon | Offers home chemotherapy, consultations, and palliative care for cancer patients. | Thane, India | 2020 |
 Anil Cancer Clinic | Offers cancer surgery, chemotherapy, and personalized care to patients in clinics. | Dombivli, India | 2014 |
 Murali subramanian | Offers cancer diagnosis and treatment services in Bangalore. | Bengaluru, India | 2020 |
Designated Partners of Sky Oncology LLP
Sky Oncology has 4 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Viraj Vilas Nevrekar Also directs: Ictc Foundation | Designated Partner | 03 Apr 2024 | 2 Years 6 Months | Current |
| Salil Vijay Patkar Also directs: Ictc Foundation | Designated Partner | 03 Aug 2023 | 3 Years 2 Months | Current |
| Rohit Ramesh Pai Also directs: Ictc Foundation | Designated Partner | 03 Aug 2023 | 3 Years 2 Months | Current |
| Amit Yeshwant Ghanekar Also directs: Ictc Foundation, A&G Milap LLP | Designated Partner | 03 Aug 2023 | 3 Years 2 Months | Current |
Financials of Sky Oncology LLP FY 2025 filings available
Sky Oncology LLP reported revenue of ₹18.06 Cr (up 283% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Sky Oncology LLP
Revenue rose 283% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Sky Oncology LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Income and Expenditure | ||
| Turnover | •••• | •••• |
| Other Income | •••• | •••• |
| Total Income | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• |
| Personnel Expenses | •••• | •••• |
| Administrative Expenses | •••• | •••• |
| Interest | •••• | •••• |
| Depreciation | •••• | •••• |
| Total Expenses | •••• | •••• |
| Profit Before Tax | •••• | •••• |
| Tax | •••• | •••• |
| Profit After Tax | ₹87.4 Lakh | •••• |
| Profit Transferred to Partners | •••• | •••• |
| Assets and Liabilities | ||
| Partners' Contribution | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Secured Loans | •••• | •••• |
| Unsecured Loans | •••• | •••• |
| Trade Payables | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Loans and Advances | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Sky Oncology LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| Net Profit Margin | 4.8% | •••• |
| Return on Partners' Funds | •••• | •••• |
| Return on Assets | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• |
| Interest Coverage | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Turnover Growth | •••• | •••• |
| Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Sky Oncology are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sky Oncology LLP
Sky Oncology LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sky Oncology LLP
Employment history and EPFO contributions of people linked to Sky Oncology.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Sky Oncology LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Sky Oncology LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sky Oncology LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sky Oncology LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sky Oncology LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Sky Oncology LLP
Frequently Asked Questions about Sky Oncology LLP
Sky Oncology is an active limited liability partnership based in Thane, Maharashtra, India. The LLP works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 03 August 2023 (3+ years old) and is registered under LLPIN ACC-3452.
Sky Oncology reported revenue of ₹18.06 Cr for FY 2025 (up 283% YoY).
Sky Oncology has 4 current designated partners:
- Viraj Vilas Nevrekar - Designated Partner
- Salil Vijay Patkar - Designated Partner
- Rohit Ramesh Pai - Designated Partner
- Amit Yeshwant Ghanekar - Designated Partner
Sky Oncology reported a net profit of ₹87.4 Lakh (net margin 4.8%) for FY 2025, as per its filed financial statements.
The LLPIN (Limited Liability Partnership Identification Number) of Sky Oncology is ACC-3452. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Sky Oncology was incorporated on 03 August 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The registered office of Sky Oncology is at Office No 47 And 48 Third Floor Plot No 77 Sector 17 Vashi Thane, Maharashtra, India – 400703.
The total obligation of contribution is ₹15 Lakh.
Sky Oncology operates in the healthcare industry, in the oncology clinics and cancer treatment segment.